Central Drug Authority Cancels Nearly 200 Medicines: What You Need to Know
in a notable move, the Central Drugs Standard Control institution (CDSCO) has announced the cancellation of nearly 200 medicines and injections, raising concerns among consumers and healthcare professionals alike. This list includes commonly used medications for fever, cold, and high blood pressure, and also several cosmetic products. the decision has left many scratching their heads, especially given the widespread use of these drugs.
The cancellation list comprises 196 items, including fixed-dose combination (FDC) drugs, which are combinations of two or more pharmaceutical ingredients in specific ratios. These FDCs, often referred to as “cocktail medicines,” include well-known medications like paracetamol, cough syrups, and allergy medications. The CDSCO conducts monthly quality checks to ensure that medicines meet specific standards, and this recent action is part of their ongoing efforts to maintain drug safety. Notably, a batch of the popular Dekka-Durabolin injection, used for managing anemia, has also been banned due to quality concerns. In April alone, samples from the non-compliant list were tested in 60 central drug laboratories and 136 state labs, underscoring the rigorous scrutiny these products face.
As the news spreads, many are left wondering about the implications for their health and the reliability of the medications they have come to trust. The CDSCO’s proactive stance aims to safeguard public health, but it also highlights the need for greater clarity and communication regarding drug safety. With the cancellation of these widely used products, consumers are urged to consult healthcare professionals for alternatives and stay informed about the medications they use.
